Offer - Urjas Oil for just ₹ 1 X
Nomosic is an allopathic medicine The correct dosage of Nomosic depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nomosic is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Nomosic safe for pregnant women?
Nomosic is safe for pregnant women.
Is the use of Nomosic safe during breastfeeding?
Breastfeeding women can safely use Nomosic.
What is the effect of Nomosic on the Kidneys?
Nomosic has very mild side effects on the kidneys.
What is the effect of Nomosic on the Liver?
The liver can be affected by Nomosic. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Nomosic only after medical advice.
What is the effect of Nomosic on the Heart?
Information about safety of Nomosic for heart is not available since scientific research on this is yet to be done.
Nomosic should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nomosic unless your doctor advises you to do so -
Is this Nomosic habit forming or addictive?
No, you will not get addicted to Nomosic.
Interaction between Food and Nomosic
Eating certain foods may increase the time it takes Nomosic to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nomosic
Due to lack of research, there is no information about the side effects of taking Nomosic with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 469
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclegis (doxylamine succinate and pyridoxine hydrochloride)